Business as unusual: medical oncology services adapt and deliver during <scp>COVID</scp>‐19Avraham Travers, James Lynam, Janine Lombard et al.|Internal Medicine Journal|2021Cited by 9
Chemoradiotherapy with concurrent durvalumab for the palliative treatment of oligometastatic oesophageal and gastrooesophageal carcinoma with dysphagia: a single arm phase II clinical trial (PALEO, sponsored by the Australasian Gastro-Intestinal Trials Group)Fiona Day, Jarad Martin, Swetha Sridharan et al.|BMC Cancer|2022Cited by 6
Mortality within 30 days of immunotherapy (checkpoint inhibitors) in metastatic cancer patients treated at Australian tertiary cancer center.Hiren Mandaliya, Girish Mallesara, Sang Kim et al.|Journal of Clinical Oncology|2019Cited by 5
REPURPOSE: PHASE II STUDY ASSESSING THE EFFICACY OF EFAVIRENZ, AN APPROVED HIV DRUG REPURPOSED AS AN ANTI-CANCER AGENT, IN PATIENTS WITH PLATINUM RESISTANT OVARIAN CANCERJanine Lombard, Nikola A. Bowden, Alison M Davis et al.|International Journal of Gynecological Cancer|2025Cited by 0